Pro Share Advisors LLC Xenon Pharmaceuticals Inc. Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 18,448 shares of XENE stock, worth $748,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,448Holding current value
$748,435% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
72.7MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$219 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$176 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$146 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$145 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$129 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.53B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...